Researchers have identified a new drug compound that appears to target tumor cells and surrounding blood vessels without the negative side effects typically associated with Cox-2 inhibitors.
Full article >>
Wednesday, April 22, 2009
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment